Trial intelligence / Profile preview

Prediction of Amitriptyline Efficacy in Migraine Prevention

NCT02101892Completed

Sponsor
Rambam Health Care Campus
Start
Apr 2014
Primary completion
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in migraine comparing Amitriptyline with Placebo (2 arms). Primary endpoint: Predictive value of the pre-treatment pain measures parameter(s) for benefit from amitriptyline treatment at 1 year. Started Apr 2014; status: completed.

02

Drugs

amitriptyline
03

Conditions

migraine

Beyond the preview

Go deeper on NCT02101892.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02101892.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call